Literature DB >> 8611660

Subunit specific monoclonal antibodies show different steady-state levels of various cytochrome-c oxidase subunits in chronic progressive external ophthalmoplegia.

J W Taanman1, M D Burton, M F Marusich, N G Kennaway, R A Capaldi.   

Abstract

Monoclonal antibodies recognizing the mitochondrially encoded subunits I and II, and the nuclear-encoded subunits IV, Va, Vb and VIc of human cytochrome-c oxidase were generated. These antibodies are highly specific and allow the assessment of subunit steady-state levels in crude cell extracts and tissue sections. In the experimental human cell line 143B206, which is devoid of mitochondrial DNA, immunovisualization with the antibodies revealed that the nuclear-encoded subunits IV and Va were present in amounts close to that of the parental cell line despite the absence of the mitochondrially encoded subunits. In contrast, the nuclear-encoded subunits Vb and VIc were severely reduced in cell line 143B206, suggesting that unassembled nuclear-encoded subunits are degraded at different rates. In skeletal muscle sections of a patient with chronic progressive external ophthalmoplegia known to harbor the 'common deletion' in a subpopulation of her mitochondrial DNA, most cytochrome-c oxidase activity negative fibers had greatly reduced levels of subunits I, II, Va, Vb and VIc of cytochrome-c oxidase. The steady-state level of subunit IV, however, was less affected. This was particularly evident in cytochrome-c oxidase activity negative fibers with accumulated mitochondria ('ragged-red' fibers) where immunodetection with anti-subunit IV resulted in intense staining. The data presented in this paper demonstrate that the battery of monoclonal antibodies can be employed for diagnostic purposes to analyze steady-state levels of mitochondrially and nuclear-encoded subunits of cytochrome-c oxidase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611660     DOI: 10.1016/0925-4439(95)00127-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Mitochondrial DNA depletion syndrome is expressed in amniotic fluid cell cultures.

Authors:  J C Blake; J W Taanman; A M Morris; R G Gray; J M Cooper; P J McKiernan; J V Leonard; A H Schapira
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

2.  Localization of mitochondrial DNA encoded cytochrome c oxidase subunits I and II in rat pancreatic zymogen granules and pituitary growth hormone granules.

Authors:  Skanda K Sadacharan; Bhag Singh; Timothy Bowes; Radhey S Gupta
Journal:  Histochem Cell Biol       Date:  2005-11-03       Impact factor: 4.304

3.  Tissue-specific cytochrome c oxidase assembly defects due to mutations in SCO2 and SURF1.

Authors:  Lukas Stiburek; Katerina Vesela; Hana Hansikova; Petr Pecina; Marketa Tesarova; Leona Cerna; Josef Houstek; Jiri Zeman
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

4.  Mitochondrial encephalomyopathy and complex III deficiency associated with a stop-codon mutation in the cytochrome b gene.

Authors:  J A Keightley; R Anitori; M D Burton; F Quan; N R Buist; N G Kennaway
Journal:  Am J Hum Genet       Date:  2000-10-20       Impact factor: 11.025

5.  A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy.

Authors:  S Rahman; J W Taanman; J M Cooper; I Nelson; I Hargreaves; B Meunier; M G Hanna; J J García; R A Capaldi; B D Lake; J V Leonard; A H Schapira
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

6.  Mitochondrial contribution to Parkinson's disease pathogenesis.

Authors:  Anthony H V Schapira; Matthew Gegg
Journal:  Parkinsons Dis       Date:  2011-04-28

7.  SCID mice containing muscle with human mitochondrial DNA mutations. An animal model for mitochondrial DNA defects.

Authors:  K M Clark; D J Watt; R N Lightowlers; M A Johnson; J B Relvas; J W Taanman; D M Turnbull
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

8.  Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA.

Authors:  M G Hanna; I P Nelson; S Rahman; R J Lane; J Land; S Heales; M J Cooper; A H Schapira; J A Morgan-Hughes; N W Wood
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

9.  Variable penetrance of a familial progressive necrotising encephalopathy due to a novel tRNA(Ile) homoplasmic mutation in the mitochondrial genome.

Authors:  A Limongelli; J Schaefer; S Jackson; F Invernizzi; Y Kirino; T Suzuki; H Reichmann; M Zeviani
Journal:  J Med Genet       Date:  2004-05       Impact factor: 6.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.